---
figid: PMC10245950__nihpp-2023.05.24.542198v2-f0012
figtitle: Glycolysis in cardiomyocytes is upregulated in the oxaliplatin treated mice
organisms:
- NA
organisms_ner:
- Homo sapiens
pmcid: PMC10245950
filename: nihpp-2023.05.24.542198v2-f0012.jpg
figlink: /pmc/articles/PMC10245950/figure/F12
number: F12
caption: 'Abbreviations of enzymes and proteins with encoded genes is in parenthesis:
  ALDOA, aldolase A (Aldoa); ALDOB, aldolase B (Aldob); ENO1/2/3, enolase 1, 2 and
  3 (Eno1, Eno2 and Eno3); GAPDH, glyceraldehyde-3-phosphate dehydrogenase (Gapdh);
  GCK, glucokinase (Gck); GLUT1, glucose transporter 1 (Slc2a1); GLUT3, glucose transporter
  3 (Slc2a3); GLUT4, glucose transporter 4; HK2, hexokinase 2/3 HK2 and HK3 (Hk2 and
  Hk3); LDHB, lactose dehydrogenase B (Ldhb); PGAM2, phosphoglycerate mutase 2 (Pgam2);
  MCT1,3,6 monocarboxylic acid transporters 1, 3, 6 (Slc16a1, Slc16a3, Slc16a6); phosphofructokinases,
  PKFL, liver type (Pfkl); PKFM, muscle type (Pfkm); and PKFP, pallet type (Pfkp);
  PKM, pyruvate kinase, muscle type (Pkm); TPI1, topoisomerase 1 (Tpi1). The schematics
  is in part based on KEGG Pathways and ref (67). Blue – upregulated genes, grey –
  unaffected genes, red downregulated genes'
papertitle: Oxaliplatin-induced cardiotoxicity in mice is connected to the changes
  in energy metabolism in the heart tissue
reftext: Junwei Du, et al. bioRxiv. 2023 May 25;NA(NA).
year: '2023'
doi: 10.1101/2023.05.24.542198
journal_title: bioRxiv
journal_nlm_ta: bioRxiv
publisher_name: Cold Spring Harbor Laboratory
keywords: oxaliplatin | cardiotoxicity | energy metabolism | glycolysis switch | Nmrk2
automl_pathway: 0.9174185
figid_alias: PMC10245950__F12
figtype: Figure
redirect_from: /figures/PMC10245950__F12
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC10245950__nihpp-2023.05.24.542198v2-f0012.html
  '@type': Dataset
  description: 'Abbreviations of enzymes and proteins with encoded genes is in parenthesis:
    ALDOA, aldolase A (Aldoa); ALDOB, aldolase B (Aldob); ENO1/2/3, enolase 1, 2 and
    3 (Eno1, Eno2 and Eno3); GAPDH, glyceraldehyde-3-phosphate dehydrogenase (Gapdh);
    GCK, glucokinase (Gck); GLUT1, glucose transporter 1 (Slc2a1); GLUT3, glucose
    transporter 3 (Slc2a3); GLUT4, glucose transporter 4; HK2, hexokinase 2/3 HK2
    and HK3 (Hk2 and Hk3); LDHB, lactose dehydrogenase B (Ldhb); PGAM2, phosphoglycerate
    mutase 2 (Pgam2); MCT1,3,6 monocarboxylic acid transporters 1, 3, 6 (Slc16a1,
    Slc16a3, Slc16a6); phosphofructokinases, PKFL, liver type (Pfkl); PKFM, muscle
    type (Pfkm); and PKFP, pallet type (Pfkp); PKM, pyruvate kinase, muscle type (Pkm);
    TPI1, topoisomerase 1 (Tpi1). The schematics is in part based on KEGG Pathways
    and ref (67). Blue – upregulated genes, grey – unaffected genes, red downregulated
    genes'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - SLC2A1
  - SLC2A3
  - SLC2A4
  - ATP8A2
  - WDTC1
  - HK1
  - KCNA4
  - KLK1
  - HOOK1
  - TAC4
  - HK2
  - KCNA5
  - KIF2A
  - KLK2
  - HOOK2
  - HK3
  - KLK3
  - HOOK3
  - GCK
  - MAP4K2
  - FAM20C
  - PIGQ
  - HT
  - CMA1
  - SLC16A1
  - MCAT
  - MCTS1
  - SLC16A3
  - SLC16A8
  - SLC16A6
  - SLC16A5
  - PGK1
  - PGAM1
  - PGAM4
  - PGAM2
  - FBP2
  - KHSRP
  - PCNX4
  - ALDOA
  - ALDOB
  - ENO1
  - ENO3
  - ENO2
  - PKM
  - GAPDH
  - GAPDHP44
  - LDHA
  - LDHB
  - Glucose
  - Insulin
  - ATP
  - ADP
  - Lactate
  - 3-phosphoglycerate
  - Dihydroxyacetone
  - Phosphoenolpyruvate
  - phosphate
  - Pyruvate
  - NAD+
  - NADH
  - 1,3-biphosphoglycerate
---
